Ensuring Business Continuity with PPD FSP
In today’s drug development climate, organizations are faced with difficult decisions of how to keep staff employed as they tackle under- and over-utilization across programs. PPD® FSP can help navigate unexpected staffing challenges by offering a dedicated staff transfer team focused on change management and business continuity.
PPD’s FSP model gives you access to highly trained talent backed by the full force of PPDs global infrastructure.
PPD FSP RECRUITS AND RETAINS TOP TALENT IN THE INDUSTRY
Ensuring quality people remain on a study is fundamental to success. We cover clients on every level, allowing them to do more with less, while providing an uncompromising commitment to quality. PPD FSP has consistently strong retention rates that translates to continuity and long-term dedication to your project. Through an enterprise-connected talent pool, supported by exceptional training, support and technology, our FSP staff has the same high standards, training, career development opportunities and support as PPD staff assigned to full-service.
STREAMLINE YOUR CAPACITY MANAGEMENT AND OVERSIGHT CHALLENGES
The absence of strong capacity management harbors resource underutilization, wasteful costs and a bored, dissatisfied team. Overutilized resources are timeline risks that generate team stress and burnout. Through an all-in-one capacity management solution called FSP Source, you can request services and teams more easily and help put resources to work wherever your program experience demands, whether at your company’s facility, one of PPD’s operations or a designated location anywhere in the world. Through this secure web application, our FSP clients have a central point for communications, demand planning and management, all while gaining access to real-time, high-quality forecasting, resourcing and operational data.
“Our team can help you flex your capacity by providing quick ramp up across any function and service, ranging from pharmacovigilance, regulatory, on-site and remote monitoring, and clinical supplies to marketed products.”
